India Corporate Governance MCA ROC Filings — March 28, 2026
Across 50 MCA Corporate Governance filings from March 28, 2026, dominant themes include overwhelming shareholder approvals (>99% in 25+ cases) for capital increases, preferential allotments, warrant conversions, and director re-appointments, signaling strong alignment on growth initiatives; routine trading window closures in 6 companies ahead of Q4/FY26 results indicate pending earnings catalysts. Promoter stake enhancements via conversions (e.g., Senores Pharma +1.9%, Ishan Dyes promoter allotment) and divestitures (Keerthi Industries electronics sale yielding INR 3.6Cr annual savings) highlight capital optimization, with positive sentiment in 65% of filings. Few risks from director/CFO resignations (IntraSoft, Hittco) and mixed votes (Grasim, Alicon with institutional opposition), but low turnout in niche cases (TEJASSVI <0.0001%) suggests shareholder apathy in microcaps. No explicit YoY revenue/margin trends, but operational shifts like Apcotex solar investments (INR 2Cr) and Aegis stake sale (INR 80Cr) point to diversification. Market implications: Bullish for small/midcaps raising equity at premiums amid control retention; portfolio trend of promoter conviction via stake hikes in 10+ firms.